🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 17 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
02/05/2006 65,30 68,80 62,00 67,90 +7,61% 10,41% 40.060
01/05/2006 62,20 64,30 62,00 63,10 -0,79% 3,70% 4.290
28/04/2006 64,70 64,90 62,90 63,60 -1,55% 3,09% 7.590
27/04/2006 64,10 64,70 62,20 64,60 +0,16% 3,90% 4.340
26/04/2006 62,50 65,30 62,30 64,50 +4,03% 4,80% 10.160
25/04/2006 64,40 65,50 62,00 62,00 -2,97% 5,43% 5.740
24/04/2006 65,30 65,30 62,00 63,90 -1,08% 5,05% 6.900
21/04/2006 66,10 66,10 63,00 64,60 -0,62% 4,69% 14.580
20/04/2006 59,50 67,80 59,40 65,00 +8,88% 14,12% 45.660
19/04/2006 60,00 60,00 57,70 59,70 +0,00% 3,83% 4.370
18/04/2006 59,20 60,20 58,10 59,70 +4,55% 3,55% 17.480
17/04/2006 56,00 58,50 55,80 57,10 +2,33% 4,82% 14.380
13/04/2006 55,80 55,90 54,90 55,80 -0,71% 1,79% 6.270
12/04/2006 56,90 58,50 55,60 56,20 +1,81% 5,10% 9.870
11/04/2006 60,10 60,10 54,00 55,20 -8,15% 10,15% 9.320
10/04/2006 59,10 60,20 57,50 60,10 +3,26% 4,57% 23.020
07/04/2006 56,00 59,20 56,00 58,20 +2,11% 5,71% 20.170
06/04/2006 55,00 57,30 54,00 57,00 +3,26% 6,00% 11.950
05/04/2006 57,00 57,00 53,90 55,20 -1,99% 5,44% 6.840
04/04/2006 54,70 57,10 54,60 56,32 +4,88% 4,57% 17.610
03/04/2006 50,70 54,00 50,60 53,70 +4,88% 6,71% 16.310
31/03/2006 50,40 52,50 50,40 51,20 +1,79% 4,17% 14.250
30/03/2006 52,10 52,80 50,30 50,30 -2,33% 4,80% 51.100
29/03/2006 54,10 54,92 51,50 51,50 -5,33% 6,32% 34.340
28/03/2006 56,70 56,70 54,40 54,40 -3,20% 4,06% 6.350
27/03/2006 56,00 56,70 53,30 56,20 +4,07% 6,07% 11.610
24/03/2006 52,00 58,10 51,90 54,00 +4,05% 11,92% 55.130
23/03/2006 50,00 52,00 49,20 51,90 +3,80% 5,60% 24.820
22/03/2006 49,00 50,00 49,00 50,00 +2,04% 2,04% 5.170
21/03/2006 50,10 50,10 49,00 49,00 -1,61% 2,20% 3.210